Overview

Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay

Status:
Unknown status
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Currently, drugs commonly used for antiplatelet are aspirin and clopidogrel when encountering stroke or coronary heart disease. In this study, we would use VASP assay and thromboelastograph with platelet mapping assay kit to evaluate the antiplatelet resistance in general population and the relationship between clopidogrel and proton pump inhibitor.
Phase:
Phase 4
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborator:
Haemonetics Corporation
Treatments:
Clopidogrel
Esomeprazole
Pantoprazole
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Rabeprazole
Ticlopidine